About the journal
Beyond Rheumatology is an open-access journal published by Verduci Editore in Italy, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Verduci Editore
- ISSN
- 2612-5110
- Country
- Italy
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 80
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.beyond-rheumatology.org/
Index listings
- DOAJ · 2023-05-08
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Dormant — no works recorded since 2022
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
80
Most recent article
9 months ago
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
47
Last recorded publication year
2022
h-index
4
i10-index
1
From OpenAlex open data (CC0).
Editorial & policy7
- Last DOAJ review date
- 2023-11-13
- Added to DOAJ
- 2023-05-08
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- No
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPKP PNPortico
- Editorial board
- Official page ↗
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Vasculitis and related conditions
- Vasculitis and related conditions
- Systemic Sclerosis and Related Diseases
- Systemic Sclerosis and Related Diseases
- Spondyloarthritis Studies and Treatments
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Rheumatoid Arthritis Research and Therapies
Show all subjects (50)
- Systemic Lupus Erythematosus Research
- Total Knee Arthroplasty Outcomes
- Bone health and osteoporosis research
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Renal Diseases and Glomerulopathies
- Orthopedic Surgery and Rehabilitation
- Total Knee Arthroplasty Outcomes
- Systemic Lupus Erythematosus Research
- Osteoarthritis Treatment and Mechanisms
- Bone health and osteoporosis research
- Osteoarthritis Treatment and Mechanisms
- Renal Diseases and Glomerulopathies
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Orthopedic Surgery and Rehabilitation
- Chronic Lymphocytic Leukemia Research
- Tendon Structure and Treatment
- Monoclonal and Polyclonal Antibodies Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Shoulder Injury and Treatment
- COVID-19 Clinical Research Studies
- Orthopedic Infections and Treatments
- Bone Metabolism and Diseases
- Mast cells and histamine
- COVID-19 Clinical Research Studies
- Shoulder Injury and Treatment
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Monoclonal and Polyclonal Antibodies Research
- Tendon Structure and Treatment
- Chronic Lymphocytic Leukemia Research
- Hip disorders and treatments
- Salivary Gland Disorders and Functions
- Bone health and treatments
- Orthopedic Infections and Treatments
- Long-Term Effects of COVID-19
- Inflammasome and immune disorders
- Bone Metabolism and Diseases
- Mast cells and histamine
- Salivary Gland Disorders and Functions
- Long-Term Effects of COVID-19
- Inflammasome and immune disorders
- Bone health and treatments
- Hip disorders and treatments
Keywords (DOAJ)
- rheumatic diseases
- osteoporosis
- fibromyalgia and related syndromes
- metabolic syndrome
- pain management
- therapies
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ